Patents by Inventor Timothy Kirk Gallaher

Timothy Kirk Gallaher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8846392
    Abstract: The present application relates to stem cells isolated from various sources within the body of a patient or of a healthy donor and identified by the presence of the interleukin 12 (IL-12) receptor. The present application also provides methods for making and for using the stem cells.
    Type: Grant
    Filed: September 27, 2011
    Date of Patent: September 30, 2014
    Assignee: Neumedicines, Inc.
    Inventors: Lena A. Basile, Timothy Kirk Gallaher
  • Publication number: 20130259828
    Abstract: The present application relates to stem cells isolated from various sources within the body of a patient or of a healthy donor and identified by the presence of the interleukin 12 (IL-12) receptor. The present application also provides methods for making and for using the stem cells.
    Type: Application
    Filed: September 27, 2011
    Publication date: October 3, 2013
    Applicant: NEUMEDICINES, INC.
    Inventors: Lena A. Basile, Timothy Kirk Gallaher
  • Publication number: 20130012452
    Abstract: The present invention is directed to methods of using HSS1 (Hematopoietic Signal peptide-containing Secreted 1), HSM1 (Hematopoietic Signal peptide-containing Membrane domain-containing 1), or a combination thereof in the treatment of various cancers, such as brain cancers.
    Type: Application
    Filed: January 27, 2011
    Publication date: January 10, 2013
    Inventors: Lena A. Basile, Timothy Kirk Gallaher
  • Patent number: 7452968
    Abstract: A novel mammalian protein system is disclosed. This system comprises a secreted protein factor and its related membrane-bound splice variant. These novel proteins have no homology to any known protein or class or protein, yet are ubiquitously expressed in nearly all tissue types. Also disclosed are novel nucleic acids that encode the novel polypeptides of the invention. The protein system was discovered in purified populations of murine hematopoieitc stem cells. The cDNAs of the invention were cloned from a marine hematopoietic lineage negative (Lin) library.
    Type: Grant
    Filed: December 31, 2003
    Date of Patent: November 18, 2008
    Assignee: University of Southern California
    Inventors: Timothy Kirk Gallaher, Lena A. Bealle, Kai-Jin Wu, Yi Zhao, Unnati Jarlwata